Merck Correlations

MRK Stock  USD 94.73  0.71  0.76%   
The current 90-days correlation between Merck Company and AbbVie Inc is 0.33 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Merck moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Merck Company moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Merck Correlation With Market

Good diversification

The correlation between Merck Company and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Moving together with Merck Stock

  0.63DSGN Design TherapeuticsPairCorr
  0.72EYEN EyenoviaPairCorr
  0.62INBX Inhibrx Symbol ChangePairCorr
  0.61LFCR Lifecore BiomedicalPairCorr
  0.7ANNX Annexon Earnings Call This WeekPairCorr
  0.61CRNX Crinetics PharmaceuticalsPairCorr

Moving against Merck Stock

  0.7OPT OptheaPairCorr
  0.79CYTH Cyclo TherapeuticsPairCorr
  0.77LUCD Lucid Diagnostics Buyout TrendPairCorr
  0.76FNA Paragon 28PairCorr
  0.76NVRO Nevro CorpPairCorr
  0.75CPIX Cumberland PharmaceuticalsPairCorr
  0.71INMD InModePairCorr
  0.53MASI MasimoPairCorr
  0.53NYXH NyxoahPairCorr
  0.45LUNG Pulmonx CorpPairCorr
  0.33NPCE NeuropacePairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Merck Stock performing well and Merck Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Merck's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.